t.nardone

TL3 Regular · Tallinn, EE

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 13 October 2024 · last posted 1d

137 posts, newest first. Showing up to 150.

The report format the maintainers ask for, and why each field is there Replied, post #5 · marked as the solution · Sourcing › Vendor reports · 26 Jul 2026 · 7 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #56 · Analytics › Home & field testing · 25 Jul 2026 · 0 likes Everything in post #54 holds. The case it does not cover is the one I have. A home refractometer is not measuring what people hope it is measuring in these…
Common supplements people ask about, assessed one at a time Replied, post #71 · Practice › Interactions · 20 Jul 2026 · 2 likes Two people in this thread mean different things by common supplements and are disagreeing about the definition while believing they are disagreeing about the facts.…
What a certificate commits its issuer to — one year on Replied, post #110 · Analytics › COA interpretation · 15 Jul 2026 · 28 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #20 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
Follow-up: How compounding permissions changed when supply normalised Replied, post #12 · Sourcing › Regulatory · 12 Jul 2026 · 19 likes Where I part company with post #8, and it is a narrow parting. Careful with the language on compounding permissions. "Not detected" and "not present" are different…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #17 · Access › Insurance & coverage · 11 Jul 2026 · 32 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #66 · Analytics › Impurities & related substances · 11 Jul 2026 · 0 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
Restarting after a long gap: what the labelling implies Replied, post #18 · Practice › Dosing & titration · 9 Jul 2026 · 11 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Ultrasound and skinfolds: operator dependence in practice Replied, post #31 · Outcomes › Body composition · 26 Jun 2026 · 2 likes Photographs under fixed lighting and posture are a genuine record and are the hardest of these to standardise.
Personal or family history of medullary thyroid carcinoma Replied, post #4 · Safety › Contraindications · 21 Jun 2026 · 0 likes Adding the measurement that the opening post says would settle it. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to…
Pooling trials with different estimands Replied, post #38 · Evidence › Meta-analyses · 21 Jun 2026 · 1 like Confirming post #36 from a second method, which matters more than confirming it from a second person. Checked the pooling trials with different estimands claim against…
Primary endpoint hierarchies and why order matters — one year on Replied, post #15 · Evidence › Trials · 14 Jun 2026 · 10 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
I joined for one answer and stayed for a year — what changed my mind Replied, post #20 · Start Here › Welcome · 13 Jun 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #96 · Practice › Reconstitution · 8 Jun 2026 · 4 likes A cake that takes a few minutes to dissolve is ordinary. A cake that will not dissolve after gentle swirling and standing at room temperature is worth raising with the…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #16 · Compounds › Secretagogues & GH axis · 2 Jun 2026 · 4 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #27 · Evidence › Journal club · 25 May 2026 · 1 like The arithmetic in post #24 is right; the assumption feeding it is the part to check. Sessions on negative or null results are consistently the most instructive and the…
A single out-of-range value on an otherwise normal panel Replied, post #44 · Clinical › Bloodwork · 9 May 2026 · 0 likes Where I part company with post #42, and it is a narrow parting. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Transporting a vial for a weekend away — a second dataset Replied, post #43 · Practice › Storage & stability · 3 May 2026 · 9 likes Where I part company with post #39, and it is a narrow parting. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the…
A checklist for reading a certificate in under two minutes Replied, post #12 · Analytics › COA interpretation · 28 Apr 2026 · 22 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Managing an unplanned gap in supply Replied, post #109 · Access › Shortages · 24 Apr 2026 · 0 likes The practical version of managing an unplanned gap is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
List price versus negotiated price versus what you pay Replied, post #106 · Access › Pricing · 17 Apr 2026 · 18 likes Confirming post #104 from a second method, which matters more than confirming it from a second person. The most useful pricing posts here are the ones that show the…
Spike-and-recover accuracy for a peptide assay Replied, post #43 · Analytics › Method validation · 8 Apr 2026 · 1 like I disagree with the framing of spike-and-recover accuracy above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
The "under review" status pill and when a moderator applies it Replied, post #54 · Evidence › Preprints · 4 Apr 2026 · 1 like Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. One case, stated as one…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #78 · Practice › Interactions · 31 Mar 2026 · 7 likes Adding thanks rather than a view. I do not have a view worth the space.
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #13 · Analytics › Mass spectrometry · 29 Mar 2026 · 0 likes Where I part company with post #9, and it is a narrow parting. Resolution and mass accuracy are different specifications. An instrument can resolve two species and…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #4 · Analytics › Mass spectrometry · 11 Mar 2026 · 20 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
The lowest dose that does anything: is that a real question? Replied, post #86 · Practice › Dosing & titration · 7 Mar 2026 · 6 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
The lowest dose that does anything: is that a real question? Replied, post #65 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
What a good consultation looks like from the other side Replied, post #20 · Clinical › Prescriber conversations · 1 Mar 2026 · 1 like Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Cost per delivered dose, which is the number that matters Replied, post #52 · Access › Pricing · 27 Feb 2026 · 0 likes A pen and a vial are not the same product. Dead volume, wastage and the number of doses actually obtainable all differ.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #11 · Research Methods › N-of-1 designs · 23 Feb 2026 · 0 likes Answering the question post #7 raises rather than the one it answers. Reading this ABAB design thread as someone who came in with a fixed view: the third and seventh…
Constipation management, with a dietitian's contribution Replied, post #33 · Practice › Side effects · 23 Feb 2026 · 21 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #106 · Clinical › Special populations · 21 Feb 2026 · 9 likes The version of older adults that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #30 · Outcomes › Body composition · 20 Feb 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #28 · Data & Tools › Datasets · 19 Feb 2026 · 0 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #21 · Practice › Dosing & titration · 15 Feb 2026 · 12 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Second pass at: Submitting a sample: the process end to end Replied, post #8 · Sourcing › Independent verification · 14 Feb 2026 · 22 likes Speaking only to Submitting a sample as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
[2026 update] What a purity-only report leaves out Replied, post #25 · Sourcing › Independent verification · 14 Feb 2026 · 0 likes Post #23 describes the usual case. This is about the unusual one. Repeat determination on the same product line months apart is the measurement that speaks to…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #86 · Documentation › Wiki requests · 13 Feb 2026 · 0 likes A request that says what the page should not cover is unusually helpful, because scope creep is what kills these. I am reporting what happened, not recommending it.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #4 · Sourcing › Red flags · 8 Feb 2026 · 23 likes This follows post #3 rather than contradicting it. Offering a way to settle supplier rather than another opinion about it. Two measurements, taken the same way, a…
Oral semaglutide bioavailability and its variability between people Replied, post #33 · Compounds › Oral incretins · 7 Feb 2026 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Reading SURMOUNT-1 without the press release — one year on Replied, post #45 · Compounds › Tirzepatide · 7 Feb 2026 · 0 likes I had written a reply contradicting post #41 and deleted it. Here is what survived. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's…
Foaming during reconstitution and whether it matters — the long version Replied, post #23 · Practice › Reconstitution · 2 Feb 2026 · 0 likes Foaming during reconstitution is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
Follow-up: Reconciling a label claim with a content assay Replied, post #4 · Analytics › COA interpretation · 29 Jan 2026 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #59 · Documentation › Wiki requests · 28 Jan 2026 · 2 likes This follows post #57 rather than contradicting it. The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #116 · Clinical › Special populations · 27 Jan 2026 · 0 likes Something worth flagging about Pregnancy and pregnancy planning: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #12 · Practice › Administration · 23 Jan 2026 · 9 likes A request rather than an answer: could whoever has the primary source for Rotating between abdomen post it? I have seen the claim three times this month and each…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #5 · Practice › Administration · 1 Jan 2026 · 4 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
Vomiting: when it is expected and when it is a reason to stop Replied, post #110 · Practice › Side effects · 30 Dec 2025 · 17 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #6 · Outcomes › Body composition · 25 Dec 2025 · 0 likes Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #109 · Compounds › Oral incretins · 24 Dec 2025 · 0 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
Waist circumference technique and its repeatability Replied, post #29 · Outcomes › Progress reports · 21 Dec 2025 · 18 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. If anyone has run this properly I would rather…
Prescription requirements and telehealth models Replied, post #60 · Sourcing › Regulatory · 11 Dec 2025 · 20 likes Two people in this thread mean different things by prescription requirements and telehealth models and are disagreeing about the definition while believing they are…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #58 · Compounds › Tirzepatide · 8 Dec 2025 · 10 likes Small correction to my own earlier position on Tirzepatide in type 2 diabetes. I had the units the wrong way round, which changes the conclusion by an order of…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #98 · Compounds › Other compounds · 26 Nov 2025 · 1 like Reading rather than contributing, but this is the most useful thread I have found on it.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #36 · Analytics › Impurities & related substances · 21 Nov 2025 · 0 likes Narrowing post #35, because the general version has more than one answer. Relative response factors mean impurities are not detected in proportion to how much of them…
Where to report an adverse event officially, by region — a second dataset Replied, post #119 · Safety › Adverse events · 11 Nov 2025 · 5 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
What a regulator's shortage notice actually authorises — what changed since Replied, post #15 · Sourcing › Regulatory · 29 Oct 2025 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
Specification in the result column: why that is a meaningful error Replied, post #61 · Analytics › COA interpretation · 21 Oct 2025 · 20 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Amylin receptor signalling and satiety Replied, post #3 · Pharmacology › Receptor biology · 19 Oct 2025 · 18 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
Sleep quality changes during weight loss — what changed since Replied, post #26 · Wellbeing › Sleep · 14 Oct 2025 · 0 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes. Somebody will…
A parcel that arrived warm: a decision process, not a verdict Replied, post #76 · Practice › Storage & stability · 9 Oct 2025 · 8 likes I read post #74 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #131 · Practice › Reconstitution · 23 Sep 2025 · 0 likes Everything in post #130 holds. The case it does not cover is the one I have. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5…
Coming back to: What published stability data actually covers, and what it does not Replied, post #142 · Practice › Storage & stability · 16 Sep 2025 · 0 likes Post #140 put the caveat in the right place and I want to underline it. Reading this published stability data actually covers thread as someone who came in with a fixed…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #136 · Data & Tools › Datasets · 11 Sep 2025 · 20 likes Fair, and the limits you put on it are the part I will remember.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #50 · Analytics › HPLC & UHPLC · 28 Aug 2025 · 0 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #14 · Analytics › Method validation · 25 Aug 2025 · 12 likes Reading rather than answering, but this is the post I would point somebody at.
Micronutrient status when intake falls substantially Replied, post #24 · Clinical › Bloodwork · 14 Aug 2025 · 6 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #40 · Documentation › Doc review · 13 Aug 2025 · 0 likes Adding the measurement that post #37 says would settle it. Promotion criteria is a good example of a question where the honest answer is boring and the interesting…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #23 · Evidence › Journal club · 12 Aug 2025 · 13 likes Post #22 is the version of this I will quote in future. One addition. Sessions on negative or null results are consistently the most instructive and the hardest to get…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #112 · Compounds › Semaglutide · 10 Aug 2025 · 25 likes Semaglutide half-life: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #90 · Compounds › Semaglutide · 28 Jul 2025 · 10 likes What would change my mind on Semaglutide half-life is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
Multiplicity when you track fifteen variables Replied, post #2 · Research Methods › Statistics · 24 Jul 2025 · 0 likes Worth separating multiplicity as a question about the compound from multiplicity as a question about the documentation. They get answered by different people and only…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #22 · Compounds › Secretagogues & GH axis · 6 Jul 2025 · 25 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Reading this reading a rodent study thread as someone who came in with a fixed view:…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #8 · Start Here › Welcome · 1 Jul 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Repeatability versus intermediate precision Replied, post #61 · Analytics › Method validation · 25 Jun 2025 · 7 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I…
Coming back to: Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 15 Jun 2025 · 24 likes Picking up post #28: that is the part I would want checked first. The arithmetic on Official shortage notices is the easy part and it is where the errors are, which is…
Coming back to: What published stability data actually covers, and what it does not Replied, post #63 · Practice › Storage & stability · 14 Jun 2025 · 0 likes Two questions I would want answered before drawing anything from the published stability data actually covers data above: how were the cases selected, and what happened…
Sodium, potassium and magnesium when intake drops Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 12 Jun 2025 · 29 likes Where there is a genuine question, a measurement answers it and a supplement does not. Blood tests for the common electrolytes are routine and cheap. The disagreement…
DXA precision and the least significant change for lean mass — the long version Replied, post #77 · Outcomes › Body composition · 22 May 2025 · 0 likes DXA precision sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Pregnancy as an absolute contraindication Replied, post #54 · Safety › Contraindications · 19 May 2025 · 13 likes On post #50 — agreed on the reasoning, with one qualification. Asking a pharmacist to check a contraindication takes minutes and is more reliable than any thread,…
Appeal templates and why they are deliberately unemotional Replied, post #2 · Access › Insurance & coverage · 13 May 2025 · 0 likes Two things can be true about appeal templates at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
The C-cell question: rodent findings and their human context Replied, post #15 · Compounds › Semaglutide · 9 May 2025 · 0 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg…
Validating a calculator against hand arithmetic — what changed since Replied, post #58 · Data & Tools › Calculators · 9 May 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Validating a calculator against hand arithmetic — what changed since Replied, post #47 · Data & Tools › Calculators · 3 May 2025 · 0 likes Picking up post #44: that is the part I would want checked first. A note on how Validating a calculator against hand gets discussed rather than on Validating a…
[2026 update] US compounding rules and how they changed Replied, post #10 · Regional › North America · 26 Apr 2025 · 15 likes Post #7 is right about the mechanism and I think understates the practical bit. Where a manufacturer runs a direct supply route, that is a commercial arrangement rather…
Counter-ion content and its effect on measured mass Replied, post #18 · Analytics › Mass spectrometry · 15 Apr 2025 · 21 likes Picking up post #15: that is the part I would want checked first. Checked the counter-ion content claim against the primary source this morning. It survives, with a…
Carryover and the ghost peak from last week's standard Replied, post #48 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 13 likes Worth separating two things that post #44 runs together. Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method…
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #17 · Practice › Administration · 7 Apr 2025 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
Retatrutide dose escalation in the published trials Replied, post #93 · Compounds › Retatrutide · 5 Apr 2025 · 12 likes Answering the question post #89 raises rather than the one it answers. On analysis: a chromatographic purity figure for an investigational compound is harder to…
Revisiting: Filter needles: when they help and what they cost you Replied, post #8 · Devices › Syringes & needles · 25 Mar 2025 · 1 like Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
Counter-ion form: the field almost nobody reports — one year on Replied, post #121 · Analytics › COA interpretation · 25 Mar 2025 · 8 likes I would rather this thread reach "we do not know" about Counter-ion form than reach a confident answer that nobody can support when asked.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #144 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Post #140 put the caveat in the right place and I want to underline it. One lot is one lot. It becomes a pattern at three or four, and the record is built to show which…
Follow-up: Open-label extensions: what survives and what does not Replied, post #10 · Evidence › Trials · 12 Mar 2025 · 27 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. A treatment-policy estimand asks what happens to people assigned to…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #2 · Compounds › Retatrutide · 10 Mar 2025 · 0 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. The reason Retatrutide mass and identity keeps being…
How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 6 Mar 2025 · 14 likes Taking post #25 at face value and following it one step further. Compounding permissions: I would want to see the raw numbers rather than the summary before agreeing.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #23 · Practice › Reconstitution · 27 Feb 2025 · 2 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #19 · Compounds › Semaglutide · 23 Feb 2025 · 0 likes Checked the SELECT claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Validating a method you did not develop — does this still hold? Replied, post #7 · Analytics › Method validation · 13 Feb 2025 · 5 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
Consistent declarations and why they matter more than clever ones Replied, post #21 · Sourcing › Logistics · 11 Feb 2025 · 19 likes Post #19 put the caveat in the right place and I want to underline it. Consistent declarations would be much easier to settle if anyone reported the denominator. Almost…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #7 · Compounds › Semaglutide · 8 Feb 2025 · 0 likes Counterpoint on SELECT, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
When "no data" is the complete and final answer Replied, post #86 · Compounds › Other compounds · 7 Feb 2025 · 24 likes This settles it for me, at least until somebody posts a reason it should not.
Reading a supplementary appendix and finding the interesting part Replied, post #82 · Evidence › Trials · 1 Feb 2025 · 0 likes Reading this reading a supplementary appendix thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Scheduled maintenance and what will be unavailable Replied, post #28 · Meta › Announcements · 29 Jan 2025 · 0 likes Post #25 answers the question as asked. The question underneath it is different. Worth separating scheduled maintenance as a question about the compound from scheduled…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #31 · Practice › Dosing & titration · 22 Jan 2025 · 0 likes Narrowing post #28, because the general version has more than one answer. The four-week step is a trial convention, not a pharmacological constant. It is roughly four…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #15 · Practice › Reconstitution · 18 Jan 2025 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
Isotonicity and what happens when you get it wrong Replied, post #26 · Pharmacology › Formulation chemistry · 13 Jan 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
Ipamorelin selectivity claims and where they came from Replied, post #6 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 14 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #38 · Compounds › Oral incretins · 10 Jan 2025 · 2 likes The most useful thing anyone has posted about Dose numbers for oral formulations in this category was a table of what had been measured and by whom. That is what I…
Recovery when intake is low: what to cut first Replied, post #10 · Nutrition & Training › Resistance training · 9 Jan 2025 · 18 likes Where the recovery discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Fixed versus detachable needles: the trade-offs Replied, post #100 · Devices › Syringes & needles · 8 Jan 2025 · 2 likes Picking up post #98: that is the part I would want checked first. I would keep fixed versus detachable needles and the decision it usually gets used for separate in…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #69 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes Useful. I have added it to my own notes with the date on it.
Body image changing more slowly than the body Replied, post #132 · Wellbeing › Mental health · 25 Dec 2024 · 8 likes Marking my uncertainty on body image explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #66 · Evidence › Journal club · 20 Dec 2024 · 1 like The strongest argument against my own position on SURPASS-2, stated as well as I can state it, since nobody else has yet.
Coming back to: When to suspect the method rather than the sample Replied, post #97 · Analytics › Method validation · 19 Dec 2024 · 3 likes Post #94 answers the question as asked. The question underneath it is different. Documented validation is what separates a number from an opinion expressed numerically.…
Body image changing more slowly than the body Replied, post #26 · Wellbeing › Mental health · 13 Dec 2024 · 18 likes Body image is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
[2026 update] New subcategory: rationale and scope Replied, post #40 · Meta › Announcements · 3 Dec 2024 · 2 likes Adding the boring version of New subcategory, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #28 · Nutrition & Training › Protein & intake · 29 Nov 2024 · 0 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here. A…
Why "any advice?" is the least effective ending for a post Replied, post #66 · Start Here › How to Ask · 23 Nov 2024 · 6 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.
Washout with a one-week half-life: the arithmetic Replied, post #10 · Research Methods › N-of-1 designs · 23 Nov 2024 · 27 likes Agreed on all of that, and I have nothing to add to it.
[2026 update] Insulin combinations and hypoglycaemia risk Replied, post #3 · Practice › Interactions · 22 Nov 2024 · 15 likes The opening post describes the usual case. This is about the unusual one. Renal or hepatic impairment changes the calculus for a lot of combinations and is the context…
Amylin and gastric emptying: overlapping mechanisms with incretins Started this topic · Compounds › Cagrilintide & amylin analogues · 20 Nov 2024 · 11 likes On the subject in the title: Amylin and gastric emptying: overlapping mechanisms with incretins Working notes rather than a conclusion. Posting a small dataset on…
EMA product information as a primary source — does this still hold? Replied, post #148 · Regional › European Union · 19 Nov 2024 · 10 likes If someone has run EMA product information properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #114 · Analytics › COA interpretation · 11 Nov 2024 · 4 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured.
Oxidation and deamidation mass shifts, tabulated Replied, post #4 · marked as the solution · Analytics › Mass spectrometry · 7 Nov 2024 · 7 likes Post #2 put the caveat in the right place and I want to underline it. Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A…
Follow-up: Dead volume across syringe and needle combinations Replied, post #54 · Devices › Syringes & needles · 24 Oct 2024 · 14 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
Second pass at: Reimbursement variation across member states Replied, post #21 · Regional › European Union · 18 Oct 2024 · 14 likes Where the Reimbursement variation across member states discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
US compounding rules and how they changed Replied, post #8 · Regional › North America · 1 Oct 2024 · 16 likes That is a fair summary of where the discussion has got to.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #60 · Practice › Dosing & titration · 9 Sep 2024 · 0 likes I had written a reply contradicting post #56 and deleted it. Here is what survived. The question underneath four-week escalation interval is usually "how would I tell?"…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #31 · Sourcing › Independent verification · 2 Sep 2024 · 0 likes Everything in post #28 holds. The case it does not cover is the one I have. Splitting a vial came up in a thread eighteen months ago and was answered well. I cannot…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #39 · Analytics › COA interpretation · 28 Aug 2024 · 13 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. I would hold that…
The C-cell question: rodent findings and their human context — what changed since Replied, post #25 · Compounds › Semaglutide · 28 Aug 2024 · 32 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Appetite effects and gastrointestinal effects are frequently reported together and…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #27 · Evidence › Journal club · 27 Aug 2024 · 1 like Adding a small correction to the SURPASS-2 summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
Circumference measurements as a poor man's composition estimate Replied, post #61 · Outcomes › Body composition · 12 Aug 2024 · 8 likes Comparing a body composition result against a population reference is a different exercise from tracking your own change, and the second is what most people want. The…
Guidelines revision: what changed and why Replied, post #10 · Meta › Announcements · 24 Jul 2024 · 4 likes Building on post #9 rather than restating it. Where I have landed on guidelines revision, having got it wrong once in public: the direction is clear, the magnitude is…
Assessing a warm arrival: the decision process — one year on Replied, post #114 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. I looked this up rather…